AI assistant
Sending…
Arcadia Biosciences, Inc. — Director's Dealing 2016
Aug 22, 2016
35424_dirs_2016-08-22_bf7cd1a0-8a7e-44a3-94db-d7d59f1463f2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2016-08-18
Reporting Person: Salameh Roger (Chief Operating Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-08-18 | Stock Option (right to buy) | $2.14 | A | 75000 | Acquired | 2026-08-17 | Common Stock (75000) | Direct |
Footnotes
F1: The option vests as to 25% of the award on the first anniversary of the date of the award (or August 18, 2017) and the remaining 75% of the award vests in 36 equal installments beginning August 31, 2017 and continuing on the last day of each of the next 35 consecutive months, with the last vesting to occur on July 31, 2020.
More from Arcadia Biosciences, Inc.
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
Apr 3
Board/Management Information
2026
Feb 6
Capital/Financing Update
2026
Jan 28
Capital/Financing Update
2026
Jan 14
M&A Activity
2025
Dec 29
Regulatory Filings
2025
Dec 29
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 23
Annual Report
2025
Nov 19